These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 18332897)

  • 1. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
    Ramasamy R; Yan SF; Schmidt AM
    Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
    Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
    Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
    Yan SF; Ramasamy R; Naka Y; Schmidt AM
    Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs).
    Collison KS; Parhar RS; Saleh SS; Meyer BF; Kwaasi AA; Hammami MM; Schmidt AM; Stern DM; Al-Mohanna FA
    J Leukoc Biol; 2002 Mar; 71(3):433-44. PubMed ID: 11867681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE, vascular tone and vascular disease.
    Farmer DG; Kennedy S
    Pharmacol Ther; 2009 Nov; 124(2):185-94. PubMed ID: 19616578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGE-RAGE and AGE Cross-link interaction: important players in the pathogenesis of diabetic kidney disease.
    Jensen LJ; Østergaard J; Flyvbjerg A
    Horm Metab Res; 2005 Apr; 37 Suppl 1():26-34. PubMed ID: 15918107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.
    Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM
    Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1208-10. PubMed ID: 15823719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE in inflammation: a new therapeutic target?
    Bierhaus A; Stern DM; Nawroth PP
    Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress.
    Herold K; Moser B; Chen Y; Zeng S; Yan SF; Ramasamy R; Emond J; Clynes R; Schmidt AM
    J Leukoc Biol; 2007 Aug; 82(2):204-12. PubMed ID: 17513693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end product receptor-mediated cellular dysfunction.
    Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
    Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.
    Foell D; Wittkowski H; Vogl T; Roth J
    J Leukoc Biol; 2007 Jan; 81(1):28-37. PubMed ID: 16943388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(2):392-4. PubMed ID: 15922119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.